in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Swedish pharma group Meda to acquire Acton Pharmaceuticals
8:56 AM MDT | August 31, 2013 | Natasha Alperowicz
Lönner: A good fit. Meda (Solna, Sweden), a specialty pharma group, says it has signed a definitive agreement to acquire the development company Acton Pharmaceuticals (Marlborough, MA), including the proprietary product Aerospan, an inhaler for the treatment of asthma that contains the active substance flunisolide. The product has recently been approved by the FDA and has shown in clinical studies to have a high deposition of active drug in the airways as a result of a built-in inhalation chamber. Under the terms of the transaction, Meda will acquire...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee